文献速递免疫规划传染病防控与疫情报告

pH调控大肠杆菌表达H1N1-RBD聚集体增强中和抗体并提供流感保护

Adjuvant-free pH-controlled aggregates of E. coli-expressed H1N1-RBD enhance neutralizing antibody responses and confer protection against influenza virus.
PubMed 文献 · Vaccine · 2026-07-11

本研究以大肠杆菌表达的H1N1-RBD(27.4 kDa)为模型,通过调节温度和pH制备不同聚集状态,并在小鼠中评估免疫原性。结果显示pH 6.0寡聚体诱导最高IgG滴度,pH 7.4聚集体中和效力最强且抗病毒攻击保护与灭活疫苗相当。

要点

  • pH 6.0寡聚体诱导最高IgG滴度,但中和效力低于聚集体。
  • pH 7.4聚集体中和效力最强,保护效果与灭活疫苗相当。
  • 三种制剂均诱导长期免疫记忆,中央记忆CD4+ T细胞占52.53-65.04%。

核心结论

  • pH调控的H1N1-RBD寡聚化/聚集可显著增强免疫原性和抗血清中和效率。

研究设计与样本

  • 使用大肠杆菌表达的H1N1-RBD(27.4 kDa),在25°C和37°C、三种pH下用DLS、SLS、CD和色氨酸荧光分析生物物理性质,并在Jcl:ICR和BALB/c小鼠中评估免疫反应。

主要发现

  • H1N1-RBD在pH 4.7主要为单体,pH 6.0形成寡聚体(Rh约20 nm),pH 7.4形成大聚集体(Rh<1000 nm)。
  • pH 6.0寡聚体诱导最高IgG滴度,pH 4.7单体和pH 7.4聚集体抗体反应较弱。
  • 三种制剂均产生中和抗血清,中和效力顺序为寡聚体<单体<聚集体(无佐剂)。
  • pH 7.4聚集体对活病毒攻击的保护与灭活流感疫苗相当(MDCK细胞空斑减少试验和BALB/c小鼠体内攻击实验)。
  • 流式细胞术显示强长期免疫记忆,中央记忆CD4+ T细胞占52.53-65.04%,CD8+ T细胞占23.81-37.85%。

临床怎么用

  • 大肠杆菌表达的H1N1-RBD可作为疫苗抗原候选。
  • pH控制的蛋白寡聚化/聚集策略可提升免疫原性和抗血清中和效率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In this study, we used the E. coli-expressed recombinant influenza H1N1 receptor-binding domain (H1N1-RBD; MW = 27.4 kDa) as a model to explore how stable oligomers or aggregates can be produced by modulating sample conditions (temperature and pH), and to examine whether such colloidal/conformational modulations enhance immunogenicity toward vaccine antigen design. We thus analyzed the biophysical properties of the protein under three different pHs at 25 °C and 37 °C using DLS, SLS, CD, and tryptophan fluorescence spectroscopy, and analyzed the immune response in mice. We found that the E. coli-expressed H1N1-RBD was predominantly monomeric at pH 4.7, oligomerized at pH 6.0 (Rh ∼ 20 nm), and formed large aggregates (Rh < 1000 nm) at pH 7.4. Immunization studies in Jcl:ICR and BALB/c mice revealed that the oligomeric form (pH 6.0) elicited the highest IgG titers, whereas the monomeric (pH 4.7) and the aggregated (pH 7.4) forms induced weaker antibody responses. Despite this, all three preparations generated neutralizing antisera, with neutralization potency increasing in the order oligomers < monomers < aggregates, in the absence of adjuvants. Notably, the aggregated H1N1-RBD conferred protection against live viral challenge comparable to that of an inactivated influenza vaccine, as demonstrated by plaque reduction assays in MDCK cells and in vivo challenge experiments in BALB/c mice. Flow cytometric analysis further revealed robust long-term immune memory, with central memory CD4+ T cells accounting for 52.53-65.04% and CD8+ T cells for 23.81-37.85% of the population. Overall, our findings highlight the potential of E. coli-produced proteins as vaccine antigens and suggest that pH-controlled protein oligomerization/aggregation can significantly boost immunogenicity and the neutralizing efficiency of antisera.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Tu T, Tseng CY, Islam MD, et al. Adjuvant-free pH-controlled aggregates of E. coli-expressed H1N1-RBD enhance neutralizing antibody responses and confer protection against influenza virus. Vaccine. 2026. PMID: 42435621. doi:10.1016/j.vaccine.2026.128898

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。